title: Intrinsic U2AF binding is modulated by exon enhancer signals in parallel with changes in splicing activity.
abstract: A functional analysis of exon replacement mutations was performed in parallel with RNA-protein binding assays to gain insight into the role of the exon in alternative and simple splicing events. These results show that constitutive exons from unrelated genes contain strong signals that promote splicing in multiple sequence contexts by enhancing 3' splice site activity. A clue to the nature of the relationship between the exon and adjacent 3' splice site is indicated by the binding properties of exon variant RNAs when tested with different biochemical preparations of the essential splicing protein, U2AF. In the context of a complete nuclear extract, U2AF binding to the 3' splice site is stimulated by the presence of an adjacent constitutive exon. In contrast, highly purified HeLa U2AF binds equivalently to the exon variants under conditions in which differential polypyrimidine tract binding is evident. These results provide support for an assisted binding model in which positive-acting signals within exons, exon enhancers, direct the binding of accessory factors, which in turn increase the intrinsic affinity of U2AF for the adjacent 3' splice site. Further support for an assisted binding model is indicated by biochemical complementation of U2AF binding and by the localization of a novel exon enhancer, which, when introduced into a weak exon, stimulates splicing activity in parallel with U2AF binding. Immunoprecipitation analysis identifies the splicing factor, SC35, as a constituent of the exon enhancer binding complex. These results are discussed in the context of current models for functional exon-bridging interactions.
mesh_terms: D001483:Base Sequence; D001667:Binding, Competitive; D003432:Cross-Linking Reagents; D004252:DNA Mutational Analysis; D005091:Exons; D006367:HeLa Cells; D006801:Humans; D008957:Models, Genetic; D008969:Molecular Sequence Data; D009687:Nuclear Proteins / Q000378:metabolism; D009843:Oligoribonucleotides / Q000378:metabolism; D011485:Protein Binding; D012313:RNA; D012326:RNA Splicing; D012261:Ribonucleoproteins / Q000378:metabolism*; D017411:Ribonucleoproteins, Small Nuclear / Q000378:metabolism; D000068103:Serine-Arginine Splicing Factors; D000072668:Splicing Factor U2AF; D014158:Transcription, Genetic; D014336:Troponin / Q000235:genetics*; D020107:Troponin T; D014466:Ultraviolet Rays
chemical_list: D003432:Cross-Linking Reagents; D009687:Nuclear Proteins; D009843:Oligoribonucleotides; C039919:RNA, recombinant; D012261:Ribonucleoproteins; D017411:Ribonucleoproteins, Small Nuclear; D000072668:Splicing Factor U2AF; D014336:Troponin; D020107:Troponin T; C000607494:U2AF2 protein, human; C073288:SRSF2 protein, human; D000068103:Serine-Arginine Splicing Factors; D012313:RNA